Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate

• Main Authors: Charmi Patel (Author), Bruno Emond (Author), Marie-Hélène Lafeuille (Author), Aurélie Côté-Sergent (Author), Patrick Lefebvre (Author), Neeta Tandon (Author), Antoine C. El Khoury (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2019-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Purpose Reducing the dosing frequency of antipsychotics (APs) with long-acting injectables (LAIs) such as once-monthly paliperidone palmitate (PP1M) can improve adherence and clinical outcomes for schizophrenia patients. This US study compared physical and psychiatric comorbidity-related ou...